Epidemiology of bronchopulmonary dysplasia

被引：124

作者：

Van Marter, Linda J. ^{[1
,2
]}

机构：

[1] Childrens Hosp, Boston, MA 02115 USA

[2] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA

来源：

SEMINARS IN FETAL & NEONATAL MEDICINE | 2009年 / 14卷 / 06期

关键词：

Bronchopulmonary dysplasia; Caffeine; Continuous positive airway pressure; Epidemiology; Inhaled nitric oxide; Non-invasive ventilation; INHALED NITRIC-OXIDE; CHRONIC LUNG-DISEASE; BIRTH-WEIGHT INFANTS; POSITIVE AIRWAY PRESSURE; RANDOMIZED CONTROLLED-TRIAL; VITAMIN-A SUPPLEMENTATION; RESPIRATORY-DISTRESS-SYNDROME; BRONCHOALVEOLAR LAVAGE FLUID; PREMATURE-INFANTS; PRETERM INFANTS;

D O I：

10.1016/j.siny.2009.08.007

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

First described more than 40 years ago, bronchopulmonary dysplasia (BPD) remains one of the most serious and vexing challenges in the care of very preterm infants. Affecting approximately one-quarter of infants born <1500 g birth weight, BPD is associated with prolonged neonatal intensive care unit hospitalization, greater risk of neonatal and post-neonatal mortality and a host of associated medical and neurodevelopmental sequelae. This seminar focuses on the epidemiology and definition of BPD as well as the current evidence pertaining to a number of potential preventive treatments for BPD: non-invasive respiratory support technologies, inhaled nitric oxide, vitamin A, and caffeine. (C) 2009 Elsevier Ltd. All rights reserved.

引用

页码：358 / 366

页数：9

共 50 条

[21] Pulmonary Hypertension in Bronchopulmonary Dysplasia
Ambalavanan, Namasivayam
Mourani, Peter
BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY, 2014, 100 (03) : 240 - 246
[22] Advances in treating bronchopulmonary dysplasia
Williams, Emma
Greenough, Anne
EXPERT REVIEW OF RESPIRATORY MEDICINE, 2019, 13 (08) : 727 - 735
[23] Bronchopulmonary Dysplasia: Clinical Perspective
Jain, Deepak
Bancalari, Eduardo
BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY, 2014, 100 (03) : 134 - 144
[24] Bronchopulmonary Dysplasia
Deakins, Kathleen M.
RESPIRATORY CARE, 2009, 54 (09) : 1252 - 1262
[25] Evidence for the Management of Bronchopulmonary Dysplasia in Very Preterm Infants
Muehlbacher, Tobias
Bassler, Dirk
Bryant, Manuel B.
CHILDREN-BASEL, 2021, 8 (04):
[26] Recent Advances in Bronchopulmonary Dysplasia: Pathophysiology, Prevention, and Treatment
Hwang, Jung S.
Rehan, Virender K.
LUNG, 2018, 196 (02) : 129 - 138
[27] Intratracheal Administration of Budesonide/Surfactant to Prevent Bronchopulmonary Dysplasia
Yeh, Tsu F.
Chen, Chung M.
Wu, Shou Y.
Husan, Zahid
Li, Tsai C.
Hsieh, Wu S.
Tsai, Chang H.
Lin, Hung C.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193 (01) : 86 - 95
[28] Bronchopulmonary dysplasia with focus on early prediction and treatment: a narrative review
Verder, Henrik
Li, Zhan-Kui
Ramanathan, Rangasamy
Clark, Howard
Sweet, David G.
Schousboe, Peter
Scoutaris, Nikolaos
Verder, Povl
Heiring, Christian
PEDIATRIC MEDICINE, 2023, 6
[29] Drugs for the Prevention and Treatment of Bronchopulmonary Dysplasia
Mandell, Erica W.
Kratimenos, Panagiotis
Abman, Steven H.
Steinhorn, Robin H.
CLINICS IN PERINATOLOGY, 2019, 46 (02) : 291 - +
[30] The 'new' bronchopulmonary dysplasia: challenges and commentary
Merritt, T. Allen
Deming, Douglas D.
Boynton, Bruce R.
SEMINARS IN FETAL & NEONATAL MEDICINE, 2009, 14 (06) : 345 - 357

← 1 2 3 4 5 →